Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mehran Baghi

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
Oncology Reports|October 25, 2008
Effects of combination treatment of bortezomib and dexamethasone in SCCHN cell lines depend on tumor cell specificityJens Wagenblast, Mehran Baghi, Christoph Arnoldner, et al.
Anticancer Research|March 2, 2005
STAT 3 activation in head and neck squamous cell carcinomas is controlled by the EGFRMarkus Hambek, Mehran Baghi, Klaus Strebhardt, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|November 2, 2025
Comparative evaluation of subtotal and total tonsillectomy in the management of chronic tonsillopharyngitis in adultsSeied-Reza Seied-Mohammad Doulabi, Alireza Moradi, Knut Engels, et al.
Anticancer Research|September 15, 2005
Iressa (ZD 1839) inhibits phosphorylation of three different downstream signal transducers in head and neck cancer (SCCHN)Markus Hambek, Mehran Baghi, Helena Baumaun, et al.
Oncology Reports|June 11, 2009
Does dexamethasone inhibit anticancer activity of cetuximab in squamous cell carcinoma cell lines of the head and neck?Jens Wagenblast, Mehran Baghi, Susanne Mörtel, et al.
Anticancer Research|August 30, 2008
Effect of bortezomib and cetuximab in EGF-stimulated HNSCCJens Wagenblast, Mehran Baghi, Christoph Arnoldner, et al.
Craniomaxillofacial Trauma & Reconstruction|November 17, 2023
The Effect of Chitohem Bleeding Inhibitor Powder on Pain and Bleeding After Tonsillectomy by Suturing MethodSeied-Reza Seied-Mohammad Doulabi, Alireza Moradi, Navid Ahmady Roozbahany, et al.
Physics in Medicine and Biology|October 9, 2007
Dynamic contrast-enhanced CT of head and neck tumors: perfusion measurements using a distributed-parameter tracer kinetic model. Initial results and comparison with deconvolution-based analysisSotirios Bisdas, George N Konstantinou, Puor Sherng Lee, et al.
Journal of Cancer Research and Clinical Oncology|October 3, 2008
Cetuximab enhances the efficacy of bortezomib in squamous cell carcinoma cell linesJens Wagenblast, Mehran Baghi, Christoph Arnoldner, et al.
European Radiology|May 17, 2006
In vivo proton MR spectroscopy of primary tumours, nodal and recurrent disease of the extracranial head and neckSotirios Bisdas, Mehran Baghi, Frank Huebner, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
Oncology Reports|October 25, 2008
Effects of combination treatment of bortezomib and dexamethasone in SCCHN cell lines depend on tumor cell specificityJens Wagenblast, Mehran Baghi, Christoph Arnoldner, et al.
Anticancer Research|March 2, 2005
STAT 3 activation in head and neck squamous cell carcinomas is controlled by the EGFRMarkus Hambek, Mehran Baghi, Klaus Strebhardt, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|November 2, 2025
Comparative evaluation of subtotal and total tonsillectomy in the management of chronic tonsillopharyngitis in adultsSeied-Reza Seied-Mohammad Doulabi, Alireza Moradi, Knut Engels, et al.
Anticancer Research|September 15, 2005
Iressa (ZD 1839) inhibits phosphorylation of three different downstream signal transducers in head and neck cancer (SCCHN)Markus Hambek, Mehran Baghi, Helena Baumaun, et al.
Oncology Reports|June 11, 2009
Does dexamethasone inhibit anticancer activity of cetuximab in squamous cell carcinoma cell lines of the head and neck?Jens Wagenblast, Mehran Baghi, Susanne Mörtel, et al.
Anticancer Research|August 30, 2008
Effect of bortezomib and cetuximab in EGF-stimulated HNSCCJens Wagenblast, Mehran Baghi, Christoph Arnoldner, et al.
Craniomaxillofacial Trauma & Reconstruction|November 17, 2023
The Effect of Chitohem Bleeding Inhibitor Powder on Pain and Bleeding After Tonsillectomy by Suturing MethodSeied-Reza Seied-Mohammad Doulabi, Alireza Moradi, Navid Ahmady Roozbahany, et al.
Physics in Medicine and Biology|October 9, 2007
Dynamic contrast-enhanced CT of head and neck tumors: perfusion measurements using a distributed-parameter tracer kinetic model. Initial results and comparison with deconvolution-based analysisSotirios Bisdas, George N Konstantinou, Puor Sherng Lee, et al.
Journal of Cancer Research and Clinical Oncology|October 3, 2008
Cetuximab enhances the efficacy of bortezomib in squamous cell carcinoma cell linesJens Wagenblast, Mehran Baghi, Christoph Arnoldner, et al.
European Radiology|May 17, 2006
In vivo proton MR spectroscopy of primary tumours, nodal and recurrent disease of the extracranial head and neckSotirios Bisdas, Mehran Baghi, Frank Huebner, et al.
Pageof 4